Clinical Trial Support
Oxford University and Hospitals Trust hosts one of the largest, most successful and respected cancer research communities in Europe, spanning a range of biological, physical and medical expertise. To ensure discoveries and advances are efficiently translated into patient benefit, Oxford Cancer supports adaptable core clinical trial infrastructure. This facility is flexible and responsive to enable scientists from a range of clinical and fundamental scientific backgrounds to translate their work into the clinic.
Funding of core capacity at the Oncology Clinical Trials Office (OCTO) and Oxford Cancer Trials Unit (OCTU) provides researchers and collaborators from any discipline, department or institute across both the University and Trust access to all the regulatory, administrative, statistical, and clinical skillsets and support needed to help you develop and deliver national or international early phase trials in which their discoveries are evaluated in the clinical setting.
Check out the Oxford cancer clinical trials webpage here for more information.
WHERE WE CAN HELP
All Oxford Cancer members are eligible to apply and access the opportunity to present their project at the interactive Clinical Trial Development Group (CTDG).
The CTDG is an informal forum of clinicians, statisticians, trial managers, pathologists, and lab scientists who will help you to refine your project and develop trial proposals, signpost opportunities for collaboration and/or translational research, and identify relevant funding calls. Through this approach, Oxford Cancer is able to maintain an active pipeline of trials which realise the patient benefit of research across Oxford.
We are always looking for new and impactful discoveries to develop, and we encourage all interested researchers to contact Oxford Cancer if they are interested in utilising this infrastructure. You don’t have to have a full trial proposal ready or be an experienced clinical investigator to bring an idea to CTDG.
If you would like to have an initial discussion about bringing your trial to OCTO please contact the OCTO Trial Development Team via email octo-trialdev@oncology.ox.ac.uk. The OCTO website has a section with more information for investigators here.
| Grant Application/Funding | Regulatory reporting | Patient/Subject Recruitment |
| Protocol Development | Risk Assessment | IMP/Drug Supplies |
| Regulatory/MHRA Approval | Data Management | Trial Master File |
| Ethics Approval | Databases | Audit |
| Pharmacovigilance | eCRFs | Compliant I.T. Systems |
| Safety | Sample Collection | CRO Management |
| Sponsorship | Analysis | Quality Systems |
| Contracts | Stakeholder reporting | NHS Site Management |
| Imaging | Radiation Therapy | First in Man Therapeutics |
| Intratumoral Injection | Device Approval |
